TLI3-12 is the first small molecule degrader. It induces anaplastic lymphoma kinase (ALK) degradation, including that in non-small-cell lung cancer (NSCLC), anaplastic large-cell lymphoma (ALCL), and neuroblastoma (NB) cell lines.

T34891

C45H53ClN10O10S

961.49

TLI312;TLI3-12

(< 1 mg/ml refers to the product slightly soluble or insoluble )
Powder: -20°C for 3 years
In solvent: -80°C for 2 years